Regarding the levels of caspase-3 no significant variation was observed following PTX administration neither in the case of normal cells neither tumor cells (Fig. 3d), suggesting the absence of caspase-3/GSDME signaling pathway. This evidence concerns the gene CASP3 and neoplasm.